AWARDBPA CALLOther than small business
BPA call 75F40122F19207BRILLIENT CORPORATION
Overview
Award facts
- Net obligations
- $401.72K
- $401,720of $401.72K potential value
- Outlays (paid to date)
- $401.72K
- $401.72K paid of $401.72K obligated$401,720
- Period of performance
- Mar 16, 2022 to Aug 26, 2024
- Ended
- Modifications
- 3
- Latest action Feb 25, 2026
- Contract type
- BPA call
- PIID 75F40122F19207
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
USER ANALYST SUPPORT III
Dates and value
- Award date
- Signed on Mar 16, 2022
- Potential end of performance
- Mar 26, 2026
- Current value
- $401,720Base and exercised options
- Potential value (if all options are exercised)
- $401,720
- Parent contract vehicle
- HHSF223201810005B (BPA, single award) — 301 orders recorded under it
Obligations by fiscal year of action
- FY2026: -$38,504 (de-obligation)
- FY2024: $80,818
- FY2023: $179,703
- FY2022: $179,703
Total across 4 fiscal years: $401,720
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 25, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationRESTON, VA
UEIMMAVC7UGLJ78
CAGE code463W1
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBRILLIENT CORPORATION
Business types and certifications
Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0001
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R499SUPPORT- PROFESSIONAL: OTHER (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Time and materialsY
Contract details
- Major program
- Professional and technial services blanket purchase agreement
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 16, 2022Base obligation at award: $179,703
- Latest action
- Feb 25, 2026 — CloseoutModification P00003; obligation change -$38,504; administrative: no change in scope or value
- Latest substantive action
- Mar 6, 2023 — Option exercisedModification P00001; obligation change +$179,703
- Actions by type
- Base award1
- Option exercised1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$38,504
- Latest action: change in base and all options
- -$38,504
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2024/2024-0600-000
- 075-X-0600-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression